Allogene Therapeutics, Inc. (ALLO) Net margin 2021–2024
Allogene Therapeutics, Inc. (ALLO) net profit margin by fiscal year — reported net income divided by reported revenue.
-1170863.6%FY2024 · since FY2021: -159.6% → -1170863.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -1170863.6% | -826374.2 pp |
| FY2023 | -344489.5% | -126275.4 pp |
| FY2022 | -218214.1% | -218054.5 pp |
| FY2021 | -159.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice